Has Ontario Failed Long-Term Care?

The Agenda with Steve Paikin

The Ontario government has promised - more than once - that it would put an iron ring around seniors in this province. But as the government's own Long-term Care Commission established, residents and staff in that sector have been devastatingly affected during the COVID-19 emergency. To discuss how and why we got here, we invite Peter Shawn Taylor, senior features editor at C2C Journal; Vivian Stamatopoulos, long-term care researcher with Ontario Tech University and co-founder of the advocacy group Doctors for Justice in LTC; Donna Duncan, CEO of the Ontario Long Term Care Association; and Pat Armstrong, distinguished research professor of sociology at York University.
Episode:
Safeguarding Seniors in Long-Term Care
Related tags:
Society
Aired:
Mar 03, 2021
Thinking of your experience with tvo.org, how likely are you to recommend tvo.org to a friend or colleague?
Not at all Likely
Extremely Likely
OPINION: A cabinet shuffle this far into the last full fiscal year of a government means that new ministers won’t make a lot of difference — and the most important posts are staying in hands Ford trusts.
TVO.org speaks with Chuck Clément, one of the producers behind the Indigenous animated series airing on TVOKids, about bringing lessons from the Seven Sacred Teachings to the screen.
OPINION: New cases are down. More and more Ontarians are vaccinated. But the numbers aren’t where we need them to be right now.
The latest coronavirus updates from across the province.
OPINION: As we get closer to the end of COVID-19, the errors and blunders we spot will matter most for the future.

According to the government’s latest briefing, more hot spots and age groups will be getting accelerated access for second shots.

In 1990, Canadian artist Heather Spears met a paramedic-in-training in East Jerusalem — sparking a relationship that would help shape a community.

The latest coronavirus updates from across the province.
TVO.org speaks with Zain Chagla and Ashleigh Tuite about AstraZeneca, degrees of protection, and weighing the risks.